Navigation Links
Alimentary Health's Probiotic Technology Launched Nationwide in the US
Date:5/12/2009

CORK, Ireland, May 12 /PRNewswire/ --

- Marketed as Align(R) by Procter & Gamble

Alimentary Health Ltd. ("Alimentary Health" or "the Company"), the specialty gastrointestinal company, welcomes today's announcement from its licensing partner Procter & Gamble (P&G), that Align, a daily probiotic supplement clinically proven to naturally defend against episodic digestive upsets, is now available nationwide in the US. Previously only available on-line and through special order from pharmacists, Align is already the US's number one gastroenterologist-recommended probiotic supplement.

Align contains Bifidobacterium infantis 35624, Alimentary Health's probiotic technology trademarked by P&G as Bifantis(R). Bifantis was developed by Alimentary Health, a global leader in the discovery, development and commercialisation of proprietary probiotic and pharmabiotic treatments for GI disorders and other inflammatory conditions, in partnership with P&G. Alimentary Health, founded in 1999 with the support of Enterprise Ireland, is one of the founding partners of the Alimentary Pharmabiotic Centre (APC), a UCC/Teagasc Research Centre focusing on gastrointestinal health and the development of new therapies for debilitating disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome. The APC was initially established with funding from Science Foundation Ireland (SFI).

Probiotics are beneficial bacteria that aid digestion and support a more desirable balance of healthy bacteria in the gastrointestinal tract. Align is the only supplement that contains Bifantis, which has been clinically proven to help promote healthy bacteria in the digestive system and to help build and maintain an ongoing natural defence against episodes of digestive imbalance such as constipation, diarrhoea, urgency, gas and bloating.

Bifantis has been independently tested and evaluated in randomized, controlled human clinical trials. The resulting data has been published in top medical journals such as Gastroenterology and the American Journal of Gastroenterology, and additional peer reviewed journals including the New England Journal of Medicine continue to cite the benefits and clinical effectiveness of Bifantis as a way to help build and maintain an ongoing natural defence against digestive imbalance. In a recent study evaluating 16 different probiotic studies, only Align was found to have efficacy against abdominal pain, bloating and bowel movement difficulty.

Barry Kiely, CEO of Alimentary Health, said: "The national launch of Align in the US is the realisation of a long and extremely successful collaboration between Alimentary Health and P&G. We are proud that our clinically proven probiotic strain will be available to consumers across the US, marketed by the best known consumer goods company in the world. Today's announcement reinforces Alimentary Health's position as the global leader in the development and commercialization of clinically supported probiotic technology."

Susan Abeln, Principal Scientist at P&G said, "There are literally hundreds of probiotic supplements on the market today, however, many factors influence how well a probiotic works, and there are critical differences between strains that many consumers may not be aware of. Procter & Gamble has spent years ensuring that Align is of the highest quality and delivers excellent results."

Notes to Editors

About Alimentary Health

Alimentary Health is a development stage speciality biotechnology company located in Ireland. The Company is focused on the discovery, development and commercialization of proprietary probiotic and pharmabiotic treatments for gastro-intestinal disorders and other inflammatory conditions. Alimentary Health is the foundation industry partner of the Alimentary Pharmabiotic Centre based at University College Cork, Ireland. http://www.alimentaryhealth.ie.

About Procter & Gamble (NYSE: PG)

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers(R), Tide(R), Ariel(R), Always(R), Whisper(R), Pantene(R), Mach3(R), Bounty(R), Dawn(R), Pringles(R), Charmin(R), Downy(R), Lenor(R), Iams(R), Crest(R), Oral-B(R), Actonel(R), Duracell(R), Olay(R), Head & Shoulders(R), Wella(R), Gillette(R), and Braun(R). The P&G community consists of almost 140,000 employees working in over 80 countries worldwide. Please visit http://www.pg.com for the latest news and in-depth information about P&G and its brands.

About Align(R)

Align is a daily probiotic supplement that helps build and maintain a strong and healthy digestive system**. Align works by providing a natural defence against episodic digestive upsets such as constipation, diarrhoea, abdominal discomfort, urgency, gas and bloating. Align is the only probiotic supplement containing the probiotic ingredient Bifantis (Bifidobacterium infantis 35624). Visit http://www.AlignGI.com for more information.

About Bifantis(R)

Bifantis (Bifidobacterium infantis 35624) is a probiotic strain that can help strengthen the body's natural defences and play an important role in basic digestion, proper metabolism and overall well-being. Bifantis is the only natural probiotic strain found in Align. Bifantis has clinically demonstrated that, when taken regularly, it can help promote normal digestive health. Capsules containing Bifantis deliver millions of good bacteria to the digestive system to restore intestinal balance and maintain normal digestive health. Visit http://www.Bifantis.com for more information.

    Contact Information:

    Financial Dynamics
    Jonathan Birt/John Dineen,
    Tel: +44-(0)20-7269-7193



'/>"/>
SOURCE Alimentary Health Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University HealthSystem Consortium Selects Sodexo to Provide Food and Nutrition Services
2. HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009
3. HealthSouth to Present at Bairds 2009 Growth Stock Conference
4. University HealthSystem Consortium Launches Tactics for Tough Times Initiative to Help Members With Issues Such as Capacity and Medication Management
5. SOURCECORP(R) HealthSERVE Unveils Unique Tool for Healthcare Providers to Support Recovery Audit Contractor (RAC) Program Defense
6. University HealthSystem Consortium Selects Morehead to Provide Employee Satisfaction and Consulting Services
7. University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum
8. HealthSouth to Hold Annual Stockholder Meeting
9. HealthSouth Announces Date of 2009 First Quarter Earnings Conference Call
10. NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters
11. University HealthSystem Consortium Selects KONE to Provide Elevator Maintenance Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: